Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$72.5M
+48.4% from 2023
Prescriptions
223K
$325.48 per claim
Patients
83K
56,029 prescribers
Total spending, 2024
$72.5M
$869.80 per patient
Medicare prescription drug plans paid $72.5M for Qvar Redihaler in 2024, for 222,708 prescriptions and refills to 83,340 patients (up 48.4% from 2023). The average cost per claim was $325.48.
California had the highest Medicare cost for Qvar Redihaler in 2024: $11.0M for 35,894 claims, followed by Michigan ($5.3M).
Luis F Velez-Quinones, internal medicine in Arecibo, PR, had the highest Medicare cost for Qvar Redihaler in 2024: 420 claims costing $94K.
Qvar Redihaler is made by Teva Pharmaceutical Industries Limited (TEVA), listed in the Medicare spending data as Teva Specialty.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Luis F Velez-Quinones Arecibo, PR | Internal Medicine | 420 | 104 | $94K |
| William Villanueva-Bosque Arecibo, PR | Pulmonary Disease | 371 | 82 | $89K |
| Joseph Grizzanti |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 35,633 | 150,543 | 48,723 | $48.4M |
| 2023 | 36,071 | 142,182 | 48,648 | $48.9M |
| 2024 | 56,029 | 222,708 | 83,340 | $72.5M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 181 |
| 55 |
| $81K |
| Podduturu S Reddy Port Huron, MI | Internal Medicine | 176 | 50 | $76K |
| Regina Frants Johnson City, NY | Pulmonary Disease | 158 | 44 | $75K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 126 | 48 | $70K |
| Reinaldo Gonzalez Martinez Bayamon, PR | Pulmonary Disease | 270 | 77 | $61K |
| Robert N Wolfe Los Angeles, CA | Pulmonary Disease | 168 | 65 | $61K |
| Robert G Shellman Shelbyville, IN | Pulmonary Disease | 181 | 33 | $59K |
| Pedro J Monroig Quiles San Juan, PR | Internal Medicine | 217 | 88 | $58K |
| Doron J Ber Waterford, CT | Allergy/ Immunology | 148 | 55 | $53K |
| Phillip W Jones Johnson City, TN | Pulmonary Disease | 152 | 36 | $46K |
| Schuman Tam San Francisco, CA | Allergy/ Immunology | 106 | 30 | $46K |
| John J Costa Buzzards Bay, MA | Allergy/ Immunology | 89 | 29 | $43K |
| Nashat H Rabadi Buffalo, NY | Pulmonary Disease | 132 | 48 | $42K |
| Eric A Libre Annandale, VA | Pulmonary Disease | 90 | 38 | $41K |
| George L Martin Wynnewood, PA | Allergy/ Immunology | 66 | 20 | $40K |
| Frederic J Scoopo Summit, NJ | Pulmonary Disease | 101 | 31 | $39K |
| Michael C Marshall West Columbia, SC | Pulmonary Disease | 118 | 35 | $38K |
| Jennifer Rankie Williamsville, NY | Physician Assistant | 105 | 33 | $38K |
| Kevin J Twohig New Haven, CT | Pulmonary Disease | 86 | 31 | $36K |
| Huan A Le San Diego, CA | Pulmonary Disease | 133 | 75 | $36K |
| Julia A Miller Johnson City, NY | Pulmonary Disease | 70 | 22 | $35K |
| Matthew D Williams Annandale, VA | Pulmonary Disease | 65 | 24 | $35K |
| Jeffrey M Bruner Clinton Twp, MI | Allergy/ Immunology | 80 | 21 | $34K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Teva Specialty TEVA | 222,782 | $72.5M |